What best means in this list
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Oncology classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
Ratings and dated fundamentals
| 1 | Exelixis Inc | EXEL | 4.5 | 2025-10-27 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $59.02 | $14,624,075,461.84 | 16.99 | 7.93 |
| 2 | Halozyme Therapeutics, Inc. | HALO | 4 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $109.84 | $12,466,620,320 | 30.14 | 86.85 |
| 3 | Johnson & Johnson | JNJ | 4 | 2025-10-22 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $256.48 | $618,090,792,158.56 | 29.38 | 7.27 |
| 4 | Krystal Biotech, Inc. Common Stock | KRYS | 4 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $327.3 | $9,687,699,022.8 | 40.12 | 7.13 |
| 5 | Eli Lilly & Co. | LLY | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1,169.6 | $1,101,011,223,224 | 41.22 | 32.5 |
| 6 | Merit Medical Systems Inc | MMSI | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $85.25 | $5,090,313,305 | 34.97 | 3.03 |
| 7 | Regeneron Pharmaceuticals Inc | REGN | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $739.57 | $76,142,420,475.16 | 17.59 | 2.4 |
| 8 | United Therapeutics Corp | UTHR | 4 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $532.78 | $22,851,302,883.76 | 17.43 | 3.57 |
| 9 | Veracyte, Inc. | VCYT | 4 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $43.6 | $3,505,035,871.6 | 30.62 | 2.52 |
| 10 | Boston Scientific Corp. | BSX | 3.5 | 2025-10-22 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $42.04 | $60,925,609,273.04 | 16.61 | Not reported |
| 11 | IDEAYA Biosciences, Inc. Common Stock | IDYA | 3.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $36.06 | $3,479,410,793.04 | Not reported | 2.9 |
| 12 | Ligand Pharmaceuticals Inc. | LGND | 3.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $295 | $5,881,004,655 | 29.82 | 6.08 |
| 13 | Lantheus Holdings, Inc | LNTH | 3.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $100.12 | $6,535,069,584.28 | 23.74 | 4.98 |
| 14 | Merck & Co., Inc. | MRK | 3.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $142.38 | $351,275,897,818.44 | 110.71 | Not reported |
| 15 | Rigel Pharmaceuticals Inc. (New) | RIGL | 3.5 | 2025-08-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $48.72 | $910,082,974.08 | 2.83 | 2.14 |
| 16 | Amgen Inc | AMGN | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $407.44 | $220,275,104,117.2 | 25.19 | Not reported |
| 17 | Corcept Therapeutics Inc. | CORT | 3 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $118.54 | $12,813,983,980.38 | 232.21 | 18.16 |
| 18 | Castle Biosciences, Inc. Common Stock | CSTL | 3 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $33.71 | $1,029,823,880.97 | Not reported | 2.19 |
| 19 | Delcath Systems Inc | DCTH | 3 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.04 | $521,869,876.8 | 980.96 | 4.31 |
| 20 | Labcorp Holdings Inc. | LH | 3 | 2025-10-31 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $314.2 | $25,481,620,000 | 25.42 | 2.96 |
| 21 | Pfizer Inc. | PFE | 3 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.82 | $158,564,919,245.98 | 36.59 | 1.85 |
| 22 | Revvity, Inc. | RVTY | 3 | 2025-10-27 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $152.16 | $16,978,986,776.16 | 71.47 | 2.35 |
| 23 | Tango Therapeutics, Inc. | TNGX | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $22.57 | $3,805,535,983.19 | Not reported | 3.71 |
| 24 | Adaptive Biotechnologies Corporation Common Stock | ADPT | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $26.09 | $4,163,855,517.78 | Not reported | 27.64 |
| 25 | Beam Therapeutics Inc. Common Stock | BEAM | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.6 | $2,540,876,559 | Not reported | 2.38 |
| 26 | Biogen Inc. Common Stock | BIIB | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $218.43 | $32,248,375,466.31 | 38.64 | 1.71 |
| 27 | Caris Life Sciences, Inc. Common Stock | CAI | 2.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.5 | $7,771,367,615 | 73.92 | 13.13 |
| 28 | CytomX Therapeutics, Inc. | CTMX | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.47 | $538,211,231.48 | Not reported | 1.78 |
| 29 | Gilead Sciences Inc | GILD | 2.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $147.1 | $182,397,403,300.5 | Not reported | Not reported |
| 30 | Incyte Genomics Inc | INCY | 2.5 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $112.75 | $22,660,234,209.25 | 14.05 | 3.57 |
| 31 | Iovance Biotherapeutics, Inc. Common Stock | IOVA | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.31 | $6,029,049,759.92 | Not reported | 8.19 |
| 32 | Keros Therapeutics, Inc. Common Stock | KROS | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $11.64 | $230,788,468.32 | Not reported | 0.88 |
| 33 | Nurix Therapeutics, Inc. Common stock | NRIX | 2.5 | 2025-10-09 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.21 | $2,304,991,179.43 | Not reported | 5.72 |
| 34 | PUMA BIOTECHNOLOGY INC | PBYI | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.97 | $514,652,058.02 | 19.26 | 3.71 |
| 35 | Pliant Therapeutics, Inc. Common Stock | PLRX | 2.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1 | $61,921,897 | Not reported | 0.42 |
| 36 | QIAGEN N.V. | QGEN | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $44.53 | $9,195,222,350 | 21.64 | 2.43 |
| 37 | Arcus Biosciences, Inc. | RCUS | 2.5 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $23.83 | $3,034,354,350.08 | Not reported | Not reported |
| 38 | Sanofi American Depositary Shares (Each representing one-half of one ordinary share) | SNY | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.23 | $98,115,104,144.16 | 11.06 | Not reported |
| 39 | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | TAK | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $18.52 | $60,614,836,586.51 | Not reported | 1.29 |
| 40 | TG Therapeutics, Inc. | TGTX | 2.5 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $53.34 | $8,164,703,287.02 | 18.49 | 13.52 |
| 41 | Zymeworks Inc. | ZYME | 2.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $25.26 | $1,792,430,427.66 | Not reported | 22.3 |
| 42 | Aclaris Therapeutics, Inc. | ACRS | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.79 | $557,883,804.47 | Not reported | 4.48 |
| 43 | Agios Pharmaceuticals, Inc. | AGIO | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $31.92 | $1,905,684,073.44 | Not reported | 1.86 |
| 44 | ALX Oncology Holdings Inc. Common Stock | ALXO | 2 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.18 | $163,166,856.46 | Not reported | 1.2 |
| 45 | Arvinas, Inc | ARVN | 2 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.51 | $491,050,294.41 | 52.8 | 0.87 |
| 46 | Atara Biotherapeutics, Inc | ATRA | 2 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.23 | $92,648,063.3 | Not reported | Not reported |
| 47 | Anavex Life Sciences | AVXL | 2 | 2025-12-22 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.54 | $142,753,136.68 | Not reported | 1.27 |
| 48 | BridgeBio Pharma, Inc. Common Stock | BBIO | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $65.04 | $12,714,505,308.96 | Not reported | Not reported |
| 49 | BridgeBio Oncology Therapeutics, Inc. Common Stock | BBOT | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.42 | $274,195,993.14 | Not reported | 0.85 |
| 50 | Black Diamond Therapeutics, Inc. Common Stock | BDTX | 2 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.81 | $103,991,282.07 | Not reported | 1.08 |
| 51 | Bristol-Myers Squibb Co. | BMY | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $59.58 | $121,704,939,204.48 | 13.11 | 5.45 |
| 52 | Cullinan Therapeutics, Inc. Common Stock | CGEM | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.46 | $994,923,569.24 | Not reported | 3.09 |
| 53 | Compass Therapeutics, Inc. Common Stock | CMPX | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.98 | $177,098,455.61 | Not reported | 1.07 |
| 54 | Cardiff Oncology, Inc. Common Stock | CRDF | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.06 | $82,462,963.94 | Not reported | 3.11 |
| 55 | Corvus Pharmaceuticals, Inc. | CRVS | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.21 | $858,874,838.24 | Not reported | 3.81 |
| 56 | Enliven Therapeutics, Inc. Common Stock | ELVN | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $40.63 | $2,976,991,019.43 | Not reported | 3.33 |
| 57 | Fulgent Genetics, Inc. Common Stock | FLGT | 2 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $20.82 | $572,868,400.26 | Not reported | 0.58 |
| 58 | Geron Corp | GERN | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.22 | $783,817,558.98 | Not reported | 3.59 |
| 59 | Genelux Corporation Common Stock | GNLX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.5 | $113,113,337.5 | Not reported | 7.02 |
| 60 | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | GSK | 2 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $46.54 | $100,420,405,755.02 | 12.11 | 4.68 |
| 61 | HUTCHMED (China) Limited American Depositary Shares | HCM | 2 | 2025-11-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $13.67 | $2,384,943,713.08 | 5.22 | 1.91 |
| 62 | Immunome, Inc. | IMNM | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $19.31 | $2,193,184,015.99 | Not reported | 4.18 |
| 63 | Janux Therapeutics, Inc. Common Stock | JANX | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $18.5 | $1,131,030,300.5 | Not reported | 1.22 |
| 64 | Kura Oncology, Inc. | KURA | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.52 | $935,865,711.88 | Not reported | 19.32 |
| 65 | Lineage Cell Therapeutics, Inc. | LCTX | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.03 | $260,494,687.92 | Not reported | 4.36 |
| 66 | MacroGenics, Inc. | MGNX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.55 | $226,135,663.85 | Not reported | 5.27 |
| 67 | Metagenomi Therapeutics, Inc. Common Stock | MGX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.99 | $37,520,220.69 | Not reported | 0.33 |
| 68 | Mirion Technologies, Inc. | MIR | 2 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $16.22 | $4,039,390,634.34 | 164.87 | 2.15 |
| 69 | Moderna, Inc. Common Stock | MRNA | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $197 | $78,649,470,133 | Not reported | 11.63 |
| 70 | NeoGenomics, Inc. | NEO | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $16.02 | $2,058,176,548.8 | Not reported | 2.62 |
| 71 | Nkarta, Inc. Common Stock | NKTX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.22 | $159,007,036.02 | Not reported | 0.64 |
| 72 | Nuvectis Pharma, Inc. Common Stock | NVCT | 2 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $20.13 | $655,866,259.29 | Not reported | 72.22 |
| 73 | Organon & Co. | OGN | 2 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.75 | $3,610,879,703.75 | 17.28 | 3.59 |
| 74 | Olema Pharmaceuticals, Inc. Common Stock | OLMA | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.82 | $684,231,286.74 | Not reported | 1.59 |
| 75 | Precipio, Inc. Common Stock | PRPO | 2 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $23.19 | $41,514,459.72 | Not reported | 2.81 |
| 76 | Replimune Group, Inc. | REPL | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.04 | $1,228,624,027.36 | Not reported | 11.63 |
| 77 | Relay Therapeutics, Inc. Common Stock | RLAY | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.41 | $3,815,255,795.71 | Not reported | 4.29 |
| 78 | Scholar Rock Holding Corporation Common Stock | SRRK | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $42.2 | $5,139,338,900.4 | Not reported | 20.25 |
| 79 | Sensus Healthcare, Inc | SRTS | 2 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.97 | $48,892,315.23 | Not reported | 1.33 |
| 80 | TScan Therapeutics, Inc. Common Stock | TCRX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.23 | $15,467,225.99 | Not reported | 0.22 |
| 81 | Teva Pharmaceutical Industries Limited | TEVA | 2 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $39.25 | $45,737,871,297 | 64.69 | 5.9 |
| 82 | Tyra Biosciences, Inc. Common Stock | TYRA | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $19.97 | $1,191,748,471.83 | Not reported | 3.37 |
| 83 | UroGen Pharma Ltd. Ordinary Shares | URGN | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $36.98 | $1,807,603,256.72 | Not reported | Not reported |
| 84 | Xencor, Inc. | XNCR | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.5 | $1,821,658,226.5 | Not reported | 3.62 |
| 85 | Zentalis Pharmaceuticals, Inc. Common Stock | ZNTL | 2 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.51 | $179,896,504.14 | Not reported | 1.25 |
| 86 | ABBVIE INC. | ABBV | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $272.42 | $481,398,090,779.7 | 76.29 | Not reported |
| 87 | Absci Corporation Common Stock | ABSI | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.94 | $1,534,229,249.4 | Not reported | 6.23 |
| 88 | Adicet Bio, Inc. Common Stock | ACET | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.74 | $53,734,952.6 | Not reported | 0.45 |
| 89 | Acrivon Therapeutics, Inc. Common Stock | ACRV | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.87 | $80,135,786.94 | Not reported | 0.92 |
| 90 | Actuate Therapeutics, Inc. Common stock | ACTU | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.68 | $16,305,643.16 | Not reported | 16.48 |
| 91 | Allogene Therapeutics, Inc. Common Stock | ALLO | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.4 | $483,687,233.4 | Not reported | 1.11 |
| 92 | American Shared Hospital Services | AMS | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.33 | $8,844,500 | Not reported | 0.34 |
| 93 | AN2 Therapeutics, Inc. Common Stock | ANTX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.68 | $176,605,589.16 | Not reported | 2.33 |
| 94 | Aprea Therapeutics, Inc. Common stock | APRE | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.56 | $7,028,372.12 | Not reported | Not reported |
| 95 | Accuray Incorporated | ARAY | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.24 | $28,832,648.71 | Not reported | 0.69 |
| 96 | Actinium Pharmaceuticals, Inc | ATNM | 1.5 | 2025-11-24 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.08 | $33,956,750.88 | 3 | 1.12 |
| 97 | Aura Biosciences, Inc. Common Stock | AURA | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.51 | $674,599,782.55 | Not reported | 2.14 |
| 98 | ArriVent BioPharma, Inc. Common Stock | AVBP | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $16.71 | $823,932,151.59 | Not reported | 2.25 |
| 99 | Bicara Therapeutics Inc. Common Stock | BCAX | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.26 | $1,142,144,840.84 | Not reported | 2.44 |
| 100 | Bullfrog AI Holdings, Inc. Common Stock | BFRG | 1.5 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.69 | $12,838,239.15 | Not reported | 1.84 |
| 101 | Biohaven Ltd. | BHVN | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.93 | $1,801,952,307.33 | Not reported | 147.44 |
| 102 | Boundless Bio, Inc. Common Stock | BOLD | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.58 | $58,689,801.3 | Not reported | 0.89 |
| 103 | BeyondSpring Inc. Ordinary Shares | BYSI | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.61 | $25,041,970.38 | Not reported | Not reported |
| 104 | Candel Therapeutics, Inc. Common Stock | CADL | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.66 | $739,169,337.9 | Not reported | 5.86 |
| 105 | C4 Therapeutics, Inc. | CCCC | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.85 | $350,621,637.6 | Not reported | 1.42 |
| 106 | Compugen Ltd | CGEN | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.12 | $200,823,203.12 | 5.68 | 1.95 |
| 107 | Coherus Oncology, Inc. Common Stock | CHRS | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.07 | $165,316,033.62 | Not reported | 2.72 |
| 108 | Calidi Biotherapeutics, Inc. | CLDI | 1.5 | 2025-08-08 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.04 | $2,687,551.36 | Not reported | 0.86 |
| 109 | Cogent Biosciences, Inc. Common Stock | COGT | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $30.08 | $5,219,631,458.56 | Not reported | 9.8 |
| 110 | Cumberland Pharmaceuticals Inc | CPIX | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.98 | $104,582,086.86 | Not reported | 6.11 |
| 111 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 1.5 | 2025-08-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $5.27 | $101,928,614.11 | Not reported | 1 |
| 112 | Curis Inc | CRIS | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.71 | $1,482,700.62 | Not reported | 0.32 |
| 113 | CRISPR Therapeutics AG | CRSP | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $50.44 | $4,877,177,417.32 | Not reported | 2.79 |
| 114 | Champions Oncology, Inc. | CSBR | 1.5 | 2025-12-16 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.98 | $69,314,473.62 | Not reported | 15.54 |
| 115 | Citius Oncology, Inc. Common Stock | CTOR | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.84 | $77,639,305.34 | Not reported | 1.92 |
| 116 | Cue Biopharma, Inc. | CUE | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.33 | $162,214,364.62 | Not reported | 70.22 |
| 117 | Editas Medicine, Inc. Common Stock | EDIT | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.84 | $436,167,299.4 | Not reported | 4.14 |
| 118 | Evolent Health, Inc Class A Common Stock | EVH | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.96 | $447,714,966.6 | Not reported | 1.17 |
| 119 | Fortress Biotech, Inc. | FBIO | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.09 | $69,620,015.08 | 0.62 | 0.34 |
| 120 | Fennec Pharmaceuticals Inc. Common Stock | FENC | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.63 | $372,763,900.17 | Not reported | 8.78 |
| 121 | Foghorn Therapeutics Inc. Common Stock | FHTX | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.99 | $118,176,776.85 | Not reported | Not reported |
| 122 | Guardant Health, Inc. Common Stock | GH | 1.5 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $165.56 | $22,217,517,905.2 | Not reported | Not reported |
| 123 | Greenwich LifeSciences, Inc. | GLSI | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.14 | $222,228,069.12 | Not reported | 71.3 |
| 124 | Monte Rosa Therapeutics, Inc. Common Stock | GLUE | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.32 | $880,434,298.32 | Not reported | 1.81 |
| 125 | GeoVax Labs, Inc. New | GOVX | 1.5 | 2025-07-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.29 | $2,112,025.04 | Not reported | 1.2 |
| 126 | Werewolf Therapeutics, Inc. Common Stock | HOWL | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.91 | $44,225,150.06 | Not reported | 2.71 |
| 127 | ImmunityBio, Inc. Common Stock | IBRX | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.91 | $10,502,977,465.43 | Not reported | Not reported |
| 128 | Immix Biopharma, Inc. Common Stock | IMMX | 1.5 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.29 | $664,600,227.06 | Not reported | 2.9 |
| 129 | IN8bio, Inc. Common Stock | INAB | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.38 | $13,604,568.54 | Not reported | 0.74 |
| 130 | Inhibrx Biosciences, Inc. Common Stock | INBX | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $92.76 | $1,365,210,141.6 | Not reported | Not reported |
| 131 | Century Therapeutics, Inc. Common Stock | IPSC | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.46 | $264,369,968.66 | Not reported | 1.14 |
| 132 | Karyopharm Therapeutics Inc. | KPTI | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.6 | $13,608,876 | Not reported | Not reported |
| 133 | Lantern Pharma Inc. Common Stock | LTRN | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.83 | $10,610,841.18 | Not reported | Not reported |
| 134 | Moleculin Biotech, Inc. | MBRX | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.42 | $3,010,400 | Not reported | 0.26 |
| 135 | MeiraGTx Holdings plc Ordinary Shares | MGTX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.5 | $1,008,451,458 | 12.77 | 4.67 |
| 136 | Medicinova, Inc. | MNOV | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.54 | $75,800,718.84 | Not reported | 2.03 |
| 137 | Monopar Therapeutics Inc. Common Stock | MNPR | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $83.98 | $563,688,204.56 | Not reported | 4.31 |
| 138 | Marker Therapeutics, Inc. Common Stock | MRKR | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.95 | $15,839,470.65 | Not reported | 1.3 |
| 139 | Myriad Genetics Inc | MYGN | 1.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.2 | $401,728,509 | Not reported | 1.32 |
| 140 | Nektar Therapeutics | NKTR | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.8 | $1,393,034,155.2 | Not reported | 1.54 |
| 141 | Intellia Therapeutics, Inc | NTLA | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $12.6 | $1,765,596,331.8 | Not reported | 2.43 |
| 142 | Nuvation Bio Inc. | NUVB | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.95 | $1,738,060,003.35 | Not reported | 6.85 |
| 143 | NovoCure Limited Ordinary Shares | NVCR | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $14.22 | $1,655,859,844.8 | Not reported | 4.9 |
| 144 | Opko Health Inc. | OPK | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.37 | $1,022,469,668.25 | Not reported | 0.86 |
| 145 | Oric Pharmaceuticals, Inc. Common Stock | ORIC | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $12.03 | $1,246,941,451.68 | Not reported | 3.27 |
| 146 | PAVmed Inc. Common Stock | PAVM | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.69 | $21,509,019.42 | Not reported | 1.11 |
| 147 | Phio Pharmaceuticals Corp. Common Stock | PHIO | 1.5 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.97 | $11,304,745.98 | Not reported | 0.9 |
| 148 | Prelude Therapeutics Incorporated | PRLD | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.88 | $309,637,521.8 | Not reported | 2.32 |
| 149 | Personalis, Inc. Common Stock | PSNL | 1.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $16.06 | $1,715,205,944.32 | Not reported | 7.29 |
| 150 | Pyxis Oncology, Inc. Common Stock | PYXS | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.99 | $165,982,019.5 | Not reported | 14.51 |
| 151 | Revolution Medicines, Inc. Common Stock | RVMD | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $188.12 | $40,320,966,954.16 | Not reported | 15.47 |
| 152 | Recursion Pharmaceuticals, Inc. Class A Common Stock | RXRX | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.95 | $2,114,601,571.5 | Not reported | 2.31 |
| 153 | Sagimet Biosciences Inc. Series A Common Stock | SGMT | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.92 | $554,455,184.76 | Not reported | 2.16 |
| 154 | SELLAS Life Sciences Group, Inc. Common Stock | SLS | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $11.26 | $2,273,908,683.34 | Not reported | 16.52 |
| 155 | Syndax Pharmaceuticals, Inc. | SNDX | 1.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $16.9 | $1,509,120,753.4 | Not reported | 99.95 |
| 156 | Shattuck Labs, Inc. Common Stock | STTK | 1.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.66 | $568,056,011.98 | Not reported | 2.69 |
| 157 | Protara Therapeutics, Inc. Common Stock | TARA | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.65 | $156,603,043.2 | Not reported | 0.97 |
| 158 | Tempus AI, Inc. Class A Common Stock | TEM | 1.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $69.28 | $12,151,086,193.76 | Not reported | 27.31 |
| 159 | Tempest Therapeutics, Inc. Common Stock | TPST | 1.5 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.77 | $12,304,146.47 | Not reported | Not reported |
| 160 | Tvardi Therapeutics, Inc. Common Stock | TVRD | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.08 | $14,406,058.44 | Not reported | 1.72 |
| 161 | Vir Biotechnology, Inc. Common Stock | VIR | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.12 | $1,881,681,452.96 | Not reported | 1.92 |
| 162 | Vanda Pharmaceuticals Inc. | VNDA | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.53 | $273,895,972.11 | Not reported | 1.24 |
| 163 | Verrica Pharmaceuticals Inc. Common Stock | VRCA | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.18 | $71,807,325.48 | Not reported | 16.67 |
| 164 | Verastem, Inc. | VSTM | 1.5 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.11 | $734,469,506.51 | Not reported | 14.69 |
| 165 | Whitehawk Therapeutics, Inc. Common Stock | WHWK | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.47 | $197,821,264.7 | Not reported | 1.08 |
| 166 | Xenetic Biosciences, Inc. | XBIO | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.12 | $4,967,543.72 | Not reported | 0.82 |
| 167 | Advanced Biomed Inc. Common Stock | ADVB | 1 | 2025-10-08 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.12 | $8,458,653.96 | 1.6 | 0.92 |
| 168 | AETHLON MEDICAL INC | AEMD | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.01 | $4,273,927.36 | Not reported | Not reported |
| 169 | Agenus Inc. | AGEN | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.54 | $339,453,868.78 | 3.69 | Not reported |
| 170 | Anixa Biosciences, Inc. | ANIX | 1 | 2025-09-25 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.91 | $101,162,663.82 | Not reported | 7.66 |
| 171 | Artelo Biosciences, Inc. Common Stock | ARTL | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-09 | $3.26 | $1,664,435.38 | Not reported | Not reported |
| 172 | Artiva Biotherapeutics, Inc. Common Stock | ARTV | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.8 | $332,452,822.8 | Not reported | 0.96 |
| 173 | Atossa Therapeutics, Inc. Common Stock | ATOS | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.42 | $24,149,901.16 | Not reported | 0.9 |
| 174 | Biodesix, Inc. Common Stock | BDSX | 1 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $25.63 | $270,425,154.34 | Not reported | 29.57 |
| 175 | bioAffinity Technologies, Inc. Common Stock | BIAF | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $5.64 | $3,046,248.6 | Not reported | 0.81 |
| 176 | Perspective Therapeutics, Inc. | CATX | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.71 | $309,351,006.73 | Not reported | 0.96 |
| 177 | Celcuity Inc. Common Stock | CELC | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $67.87 | $3,321,008,595.96 | Not reported | Not reported |
| 178 | Celularity Inc. Class A Common Stock | CELU | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.46 | $42,261,103.06 | Not reported | Not reported |
| 179 | Context Therapeutics Inc. Common Stock | CNTX | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.3 | $27,471,873.92 | Not reported | 0.72 |
| 180 | Caribou Biosciences, Inc. Common Stock | CRBU | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.48 | $51,588,255.26 | Not reported | 0.53 |
| 181 | Cel-Sci Corporation | CVM | 1 | 2025-12-23 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.95 | $34,298,524.65 | Not reported | 3.13 |
| 182 | Elicio Therapeutics, Inc. Common Stock | ELTX | 1 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.81 | $47,570,206.42 | Not reported | 5.99 |
| 183 | Equillium, Inc. Common Stock | EQ | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.44 | $91,307,638.08 | Not reported | 1.63 |
| 184 | Estrella Immunopharma, Inc. Common Stock | ESLA | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.42 | $18,160,358.22 | Not reported | Not reported |
| 185 | Evotec SE American Depositary Shares | EVO | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.57 | $558,225,767.98 | Not reported | Not reported |
| 186 | Fate Therapeutics, Inc. | FATE | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.13 | $255,217,694.82 | Not reported | Not reported |
| 187 | Galectin Therapeutics Inc. | GALT | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.64 | $367,092,704.16 | Not reported | Not reported |
| 188 | Gain Therapeutics, Inc. Common Stock | GANX | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.62 | $70,484,444.69 | Not reported | 6.24 |
| 189 | Genprex, Inc. Common Stock | GNPX | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.75 | $2,254,199.75 | Not reported | 0.15 |
| 190 | HCW Biologics Inc. Common Stock | HCWB | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.53 | $2,809,575.72 | Not reported | 0.38 |
| 191 | Heron Therapeutics, Inc. | HRTX | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.36 | $68,005,096.37 | Not reported | 9.84 |
| 192 | TuHURA Biosciences, Inc. Common Stock | HURA | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.93 | $122,992,370.81 | Not reported | 6.65 |
| 193 | iBio, Inc. Common Stock | IBIO | 1 | 2025-09-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.92 | $59,162,675.52 | Not reported | 0.69 |
| 194 | Impact BioMedical, Inc. | IBO | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.11 | $35,114,520.69 | 44.51 | 2.51 |
| 195 | Inhibikase Therapeutics, Inc. Common Stock | IKT | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.91 | $266,513,569 | Not reported | 1.74 |
| 196 | Insight Molecular Diagnostics Inc. Common Stock | IMDX | 1 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.28 | $107,335,651.52 | Not reported | Not reported |
| 197 | Imunon, Inc. Common Stock | IMNN | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.07 | $6,004,201.21 | Not reported | 1.43 |
| 198 | Immuneering Corporation Class A Common Stock | IMRX | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.74 | $241,968,283.48 | Not reported | 1.27 |
| 199 | Indaptus Therapeutics, Inc. Common Stock | INDP | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.37 | $268,384,307.88 | Not reported | 23.6 |
| 200 | MiNK Therapeutics, Inc. Common Stock | INKT | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11 | $56,133,022 | Not reported | Not reported |
| 201 | INmune Bio Inc. Common stock | INMB | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.83 | $50,789,433.87 | Not reported | 2.49 |
| 202 | Inovio Pharmaceuticals, Inc. | INO | 1 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.09 | $112,703,294.62 | Not reported | 25.78 |
| 203 | Intensity Therapeutics, Inc. Common stock | INTS | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.68 | $12,014,754.72 | Not reported | 1.3 |
| 204 | INVO Fertility, Inc. Common Stock | IVF | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.74 | $1,855,407.76 | Not reported | 0.11 |
| 205 | Kairos Pharma, Ltd. | KAPA | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.96 | $3,248,274.99 | Not reported | Not reported |
| 206 | Pasithea Therapeutics Corp. Common Stock | KTTA | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.44 | $14,732,430.12 | Not reported | 0.3 |
| 207 | Liminatus Pharma, Inc. Class A Common Stock | LIMN | 1 | 2025-10-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.69 | $4,956,433.83 | Not reported | 16.49 |
| 208 | Lite Strategy, Inc. Common Stock | LITS | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.22 | $37,096,866.96 | Not reported | 0.89 |
| 209 | Lunai Bioworks Inc. Common Stock | LNAI | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.12 | $5,077,956.8 | Not reported | Not reported |
| 210 | Lisata Therapeutics, Inc. Common Stock | LSTA | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.2 | $10,813,124.4 | Not reported | 1.35 |
| 211 | Lucid Diagnostics Inc. Common Stock | LUCD | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.65 | $132,128,904.9 | Not reported | 12.09 |
| 212 | MAIA Biotechnology, Inc. | MAIA | 1 | 2025-11-27 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.15 | $69,949,720.6 | Not reported | 3.38 |
| 213 | Medicus Pharma Ltd. Common Stock | MDCX | 1 | 2025-11-21 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.1 | $6,438,104.16 | Not reported | Not reported |
| 214 | MDxHealth SA Ordinary Shares | MDXH | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.58 | $55,389,790.25 | Not reported | Not reported |
| 215 | Neuphoria Therapeutics Inc. Common Stock | NEUP | 1 | 2025-09-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.35 | $100,710.94 | Not reported | 0 |
| 216 | NeOnc Technologies Holdings, Inc. Common Stock | NTHI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.53 | $65,619,003.45 | Not reported | Not reported |
| 217 | NextCure, Inc. Common Stock | NXTC | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.78 | $31,034,494.02 | Not reported | 2.55 |
| 218 | OnKure Therapeutics, Inc. Class A Common Stock | OKUR | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.3 | $93,141,510.7 | Not reported | 0.54 |
| 219 | Omeros Corporation | OMER | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $19.12 | $1,384,064,601.92 | 11.09 | Not reported |
| 220 | Onconetix, Inc. Common Stock | ONCO | 1 | 2025-11-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.65 | $2,583,900.71 | Not reported | 0.19 |
| 221 | OS Therapies Incorporated | OSTX | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.62 | $74,723,836.5 | Not reported | Not reported |
| 222 | Processa Pharmaceuticals, Inc. Common | PCSA | 1 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.35 | $3,771,071.1 | Not reported | Not reported |
| 223 | PDS Biotechnology Corporation Common Stock | PDSB | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.02 | $57,090,764.76 | Not reported | Not reported |
| 224 | Precigen, Inc. Common Stock | PGEN | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.6 | $2,721,067,877.2 | Not reported | 62.44 |
| 225 | PharmaCyte Biotech, Inc. Common Stock | PMCB | 1 | 2025-12-24 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.4 | $4,266,346.91 | Not reported | 0.14 |
| 226 | PMV Pharmaceuticals, Inc | PMVP | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.49 | $79,652,506.42 | Not reported | 1.11 |
| 227 | PolyPid Ltd. Ordinary Shares | PYPD | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.9 | $99,527,653.4 | Not reported | 9.07 |
| 228 | Rafael Holdings, Inc. Class B Common Stock | RFL | 1 | 2025-12-15 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.48 | $76,959,994.08 | Not reported | 0.95 |
| 229 | Relmada Therapeutics, Inc. Common Stock | RLMD | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.17 | $338,143,411.82 | Not reported | 1.64 |
| 230 | RenovoRx, Inc. Common Stock | RNXT | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.33 | $60,022,245.64 | Not reported | 6.68 |
| 231 | Shuttle Pharmaceuticals Holdings, Inc. Common Stock | SHPH | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.55 | $5,556,465.75 | Not reported | 0.29 |
| 232 | Summit Therapeutics Inc. Common Stock | SMMT | 1 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.17 | $13,697,360,666.34 | Not reported | 21.74 |
| 233 | Senti Biosciences Holdings, Inc. Common Stock | SNTI | 1 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.32 | $10,019,267.36 | Not reported | Not reported |
| 234 | Sutro Biopharma, Inc. | STRO | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.32 | $254,023,539.72 | Not reported | Not reported |
| 235 | Alaunos Therapeutics, Inc. Common Stock | TCRT | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.78 | $1,984,114.88 | Not reported | 3.04 |
| 236 | Telomir Pharmaceuticals, Inc. Common Stock | TELO | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.15 | $79,091,199.4 | Not reported | 15.71 |
| 237 | TriSalus Life Sciences, Inc. Common Stock | TLSI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.13 | $254,303,098 | Not reported | 38.82 |
| 238 | Theriva Biologics, Inc. | TOVX | 1 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.23 | $10,422,224.9 | Not reported | 0.86 |
| 239 | Traws Pharma, Inc. Common Stock | TRAW | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.48 | $7,381,383.44 | Not reported | 4.37 |
| 240 | Tevogen Inc. Common Stock | TVGN | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.06 | $45,971,472.4 | Not reported | Not reported |
| 241 | Veru Inc. | VERU | 1 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.42 | $41,261,774.4 | Not reported | 1.45 |
| 242 | VolitionRx Limited | VNRX | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.22 | $2,994,674.85 | Not reported | Not reported |
| 243 | Vor Biopharma Inc. Common Stock | VOR | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $19.13 | $1,131,774,684.22 | 1.8 | Not reported |
| 244 | XBiotech Inc | XBIT | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.2 | $67,073,008.2 | Not reported | 0.52 |
| 245 | Xilio Therapeutics, Inc. Common Stock | XLO | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.01 | $59,287,142.49 | Not reported | 0.82 |
No matching rows. Clear the filter to see all records.
245 companies with eligible ratings and dated fundamentals, from 330 eligible companies in this selection.
Exelixis Inc (EXEL) ↗Halozyme Therapeutics, Inc. (HALO) ↗Johnson & Johnson (JNJ) ↗Krystal Biotech, Inc. Common Stock (KRYS) ↗Eli Lilly & Co. (LLY) ↗Merit Medical Systems Inc (MMSI) ↗Regeneron Pharmaceuticals Inc (REGN) ↗United Therapeutics Corp (UTHR) ↗Veracyte, Inc. (VCYT) ↗Boston Scientific Corp. (BSX) ↗IDEAYA Biosciences, Inc. Common Stock (IDYA) ↗Ligand Pharmaceuticals Inc. (LGND) ↗Lantheus Holdings, Inc (LNTH) ↗Merck & Co., Inc. (MRK) ↗Rigel Pharmaceuticals Inc. (New) (RIGL) ↗Amgen Inc (AMGN) ↗Corcept Therapeutics Inc. (CORT) ↗Castle Biosciences, Inc. Common Stock (CSTL) ↗Delcath Systems Inc (DCTH) ↗Labcorp Holdings Inc. (LH) ↗Pfizer Inc. (PFE) ↗Revvity, Inc. (RVTY) ↗Tango Therapeutics, Inc. (TNGX) ↗Adaptive Biotechnologies Corporation Common Stock (ADPT) ↗Beam Therapeutics Inc. Common Stock (BEAM) ↗Biogen Inc. Common Stock (BIIB) ↗Caris Life Sciences, Inc. Common Stock (CAI) ↗CytomX Therapeutics, Inc. (CTMX) ↗Gilead Sciences Inc (GILD) ↗Incyte Genomics Inc (INCY) ↗Iovance Biotherapeutics, Inc. Common Stock (IOVA) ↗Keros Therapeutics, Inc. Common Stock (KROS) ↗Nurix Therapeutics, Inc. Common stock (NRIX) ↗PUMA BIOTECHNOLOGY INC (PBYI) ↗Pliant Therapeutics, Inc. Common Stock (PLRX) ↗QIAGEN N.V. (QGEN) ↗Arcus Biosciences, Inc. (RCUS) ↗Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) ↗Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) ↗TG Therapeutics, Inc. (TGTX) ↗Zymeworks Inc. (ZYME) ↗Aclaris Therapeutics, Inc. (ACRS) ↗Agios Pharmaceuticals, Inc. (AGIO) ↗ALX Oncology Holdings Inc. Common Stock (ALXO) ↗Arvinas, Inc (ARVN) ↗Atara Biotherapeutics, Inc (ATRA) ↗Anavex Life Sciences (AVXL) ↗BridgeBio Pharma, Inc. Common Stock (BBIO) ↗BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) ↗Black Diamond Therapeutics, Inc. Common Stock (BDTX) ↗Bristol-Myers Squibb Co. (BMY) ↗Cullinan Therapeutics, Inc. Common Stock (CGEM) ↗Compass Therapeutics, Inc. Common Stock (CMPX) ↗Cardiff Oncology, Inc. Common Stock (CRDF) ↗Corvus Pharmaceuticals, Inc. (CRVS) ↗Enliven Therapeutics, Inc. Common Stock (ELVN) ↗Fulgent Genetics, Inc. Common Stock (FLGT) ↗Geron Corp (GERN) ↗Genelux Corporation Common Stock (GNLX) ↗GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) ↗HUTCHMED (China) Limited American Depositary Shares (HCM) ↗Immunome, Inc. (IMNM) ↗Janux Therapeutics, Inc. Common Stock (JANX) ↗Kura Oncology, Inc. (KURA) ↗Lineage Cell Therapeutics, Inc. (LCTX) ↗MacroGenics, Inc. (MGNX) ↗Metagenomi Therapeutics, Inc. Common Stock (MGX) ↗Mirion Technologies, Inc. (MIR) ↗Moderna, Inc. Common Stock (MRNA) ↗NeoGenomics, Inc. (NEO) ↗Nkarta, Inc. Common Stock (NKTX) ↗Nuvectis Pharma, Inc. Common Stock (NVCT) ↗Organon & Co. (OGN) ↗Olema Pharmaceuticals, Inc. Common Stock (OLMA) ↗Precipio, Inc. Common Stock (PRPO) ↗Replimune Group, Inc. (REPL) ↗Relay Therapeutics, Inc. Common Stock (RLAY) ↗Scholar Rock Holding Corporation Common Stock (SRRK) ↗Sensus Healthcare, Inc (SRTS) ↗TScan Therapeutics, Inc. Common Stock (TCRX) ↗Teva Pharmaceutical Industries Limited (TEVA) ↗Tyra Biosciences, Inc. Common Stock (TYRA) ↗UroGen Pharma Ltd. Ordinary Shares (URGN) ↗Xencor, Inc. (XNCR) ↗Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) ↗ABBVIE INC. (ABBV) ↗Absci Corporation Common Stock (ABSI) ↗Adicet Bio, Inc. Common Stock (ACET) ↗Acrivon Therapeutics, Inc. Common Stock (ACRV) ↗Actuate Therapeutics, Inc. Common stock (ACTU) ↗Allogene Therapeutics, Inc. Common Stock (ALLO) ↗American Shared Hospital Services (AMS) ↗AN2 Therapeutics, Inc. Common Stock (ANTX) ↗Aprea Therapeutics, Inc. Common stock (APRE) ↗Accuray Incorporated (ARAY) ↗Actinium Pharmaceuticals, Inc (ATNM) ↗Aura Biosciences, Inc. Common Stock (AURA) ↗ArriVent BioPharma, Inc. Common Stock (AVBP) ↗Bicara Therapeutics Inc. Common Stock (BCAX) ↗Bullfrog AI Holdings, Inc. Common Stock (BFRG) ↗Biohaven Ltd. (BHVN) ↗Boundless Bio, Inc. Common Stock (BOLD) ↗BeyondSpring Inc. Ordinary Shares (BYSI) ↗Candel Therapeutics, Inc. Common Stock (CADL) ↗C4 Therapeutics, Inc. (CCCC) ↗Compugen Ltd (CGEN) ↗Coherus Oncology, Inc. Common Stock (CHRS) ↗Calidi Biotherapeutics, Inc. (CLDI) ↗Cogent Biosciences, Inc. Common Stock (COGT) ↗Cumberland Pharmaceuticals Inc (CPIX) ↗Corbus Pharmaceuticals Holdings, Inc. (CRBP) ↗Curis Inc (CRIS) ↗CRISPR Therapeutics AG (CRSP) ↗Champions Oncology, Inc. (CSBR) ↗Citius Oncology, Inc. Common Stock (CTOR) ↗Cue Biopharma, Inc. (CUE) ↗Editas Medicine, Inc. Common Stock (EDIT) ↗Evolent Health, Inc Class A Common Stock (EVH) ↗Fortress Biotech, Inc. (FBIO) ↗Fennec Pharmaceuticals Inc. Common Stock (FENC) ↗Foghorn Therapeutics Inc. Common Stock (FHTX) ↗Guardant Health, Inc. Common Stock (GH) ↗Greenwich LifeSciences, Inc. (GLSI) ↗Monte Rosa Therapeutics, Inc. Common Stock (GLUE) ↗GeoVax Labs, Inc. New (GOVX) ↗Werewolf Therapeutics, Inc. Common Stock (HOWL) ↗ImmunityBio, Inc. Common Stock (IBRX) ↗Immix Biopharma, Inc. Common Stock (IMMX) ↗IN8bio, Inc. Common Stock (INAB) ↗Inhibrx Biosciences, Inc. Common Stock (INBX) ↗Century Therapeutics, Inc. Common Stock (IPSC) ↗Karyopharm Therapeutics Inc. (KPTI) ↗Lantern Pharma Inc. Common Stock (LTRN) ↗Moleculin Biotech, Inc. (MBRX) ↗MeiraGTx Holdings plc Ordinary Shares (MGTX) ↗Medicinova, Inc. (MNOV) ↗Monopar Therapeutics Inc. Common Stock (MNPR) ↗Marker Therapeutics, Inc. Common Stock (MRKR) ↗Myriad Genetics Inc (MYGN) ↗Nektar Therapeutics (NKTR) ↗Intellia Therapeutics, Inc (NTLA) ↗Nuvation Bio Inc. (NUVB) ↗NovoCure Limited Ordinary Shares (NVCR) ↗Opko Health Inc. (OPK) ↗Oric Pharmaceuticals, Inc. Common Stock (ORIC) ↗PAVmed Inc. Common Stock (PAVM) ↗Phio Pharmaceuticals Corp. Common Stock (PHIO) ↗Prelude Therapeutics Incorporated (PRLD) ↗Personalis, Inc. Common Stock (PSNL) ↗Pyxis Oncology, Inc. Common Stock (PYXS) ↗Revolution Medicines, Inc. Common Stock (RVMD) ↗Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) ↗Sagimet Biosciences Inc. Series A Common Stock (SGMT) ↗SELLAS Life Sciences Group, Inc. Common Stock (SLS) ↗Syndax Pharmaceuticals, Inc. (SNDX) ↗Shattuck Labs, Inc. Common Stock (STTK) ↗Protara Therapeutics, Inc. Common Stock (TARA) ↗Tempus AI, Inc. Class A Common Stock (TEM) ↗Tempest Therapeutics, Inc. Common Stock (TPST) ↗Tvardi Therapeutics, Inc. Common Stock (TVRD) ↗Vir Biotechnology, Inc. Common Stock (VIR) ↗Vanda Pharmaceuticals Inc. (VNDA) ↗Verrica Pharmaceuticals Inc. Common Stock (VRCA) ↗Verastem, Inc. (VSTM) ↗Whitehawk Therapeutics, Inc. Common Stock (WHWK) ↗Xenetic Biosciences, Inc. (XBIO) ↗Advanced Biomed Inc. Common Stock (ADVB) ↗AETHLON MEDICAL INC (AEMD) ↗Agenus Inc. (AGEN) ↗Anixa Biosciences, Inc. (ANIX) ↗Artelo Biosciences, Inc. Common Stock (ARTL) ↗Artiva Biotherapeutics, Inc. Common Stock (ARTV) ↗Atossa Therapeutics, Inc. Common Stock (ATOS) ↗Biodesix, Inc. Common Stock (BDSX) ↗bioAffinity Technologies, Inc. Common Stock (BIAF) ↗Perspective Therapeutics, Inc. (CATX) ↗Celcuity Inc. Common Stock (CELC) ↗Celularity Inc. Class A Common Stock (CELU) ↗Context Therapeutics Inc. Common Stock (CNTX) ↗Caribou Biosciences, Inc. Common Stock (CRBU) ↗Cel-Sci Corporation (CVM) ↗Elicio Therapeutics, Inc. Common Stock (ELTX) ↗Equillium, Inc. Common Stock (EQ) ↗Estrella Immunopharma, Inc. Common Stock (ESLA) ↗Evotec SE American Depositary Shares (EVO) ↗Fate Therapeutics, Inc. (FATE) ↗Galectin Therapeutics Inc. (GALT) ↗Gain Therapeutics, Inc. Common Stock (GANX) ↗Genprex, Inc. Common Stock (GNPX) ↗HCW Biologics Inc. Common Stock (HCWB) ↗Heron Therapeutics, Inc. (HRTX) ↗TuHURA Biosciences, Inc. Common Stock (HURA) ↗iBio, Inc. Common Stock (IBIO) ↗Impact BioMedical, Inc. (IBO) ↗Inhibikase Therapeutics, Inc. Common Stock (IKT) ↗Insight Molecular Diagnostics Inc. Common Stock (IMDX) ↗Imunon, Inc. Common Stock (IMNN) ↗Immuneering Corporation Class A Common Stock (IMRX) ↗Indaptus Therapeutics, Inc. Common Stock (INDP) ↗MiNK Therapeutics, Inc. Common Stock (INKT) ↗INmune Bio Inc. Common stock (INMB) ↗Inovio Pharmaceuticals, Inc. (INO) ↗Intensity Therapeutics, Inc. Common stock (INTS) ↗INVO Fertility, Inc. Common Stock (IVF) ↗Kairos Pharma, Ltd. (KAPA) ↗Pasithea Therapeutics Corp. Common Stock (KTTA) ↗Liminatus Pharma, Inc. Class A Common Stock (LIMN) ↗Lite Strategy, Inc. Common Stock (LITS) ↗Lunai Bioworks Inc. Common Stock (LNAI) ↗Lisata Therapeutics, Inc. Common Stock (LSTA) ↗Lucid Diagnostics Inc. Common Stock (LUCD) ↗MAIA Biotechnology, Inc. (MAIA) ↗Medicus Pharma Ltd. Common Stock (MDCX) ↗MDxHealth SA Ordinary Shares (MDXH) ↗Neuphoria Therapeutics Inc. Common Stock (NEUP) ↗NeOnc Technologies Holdings, Inc. Common Stock (NTHI) ↗NextCure, Inc. Common Stock (NXTC) ↗OnKure Therapeutics, Inc. Class A Common Stock (OKUR) ↗Omeros Corporation (OMER) ↗Onconetix, Inc. Common Stock (ONCO) ↗OS Therapies Incorporated (OSTX) ↗Processa Pharmaceuticals, Inc. Common (PCSA) ↗PDS Biotechnology Corporation Common Stock (PDSB) ↗Precigen, Inc. Common Stock (PGEN) ↗PharmaCyte Biotech, Inc. Common Stock (PMCB) ↗PMV Pharmaceuticals, Inc (PMVP) ↗PolyPid Ltd. Ordinary Shares (PYPD) ↗Rafael Holdings, Inc. Class B Common Stock (RFL) ↗Relmada Therapeutics, Inc. Common Stock (RLMD) ↗RenovoRx, Inc. Common Stock (RNXT) ↗Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) ↗Summit Therapeutics Inc. Common Stock (SMMT) ↗Senti Biosciences Holdings, Inc. Common Stock (SNTI) ↗Sutro Biopharma, Inc. (STRO) ↗Alaunos Therapeutics, Inc. Common Stock (TCRT) ↗Telomir Pharmaceuticals, Inc. Common Stock (TELO) ↗TriSalus Life Sciences, Inc. Common Stock (TLSI) ↗Theriva Biologics, Inc. (TOVX) ↗Traws Pharma, Inc. Common Stock (TRAW) ↗Tevogen Inc. Common Stock (TVGN) ↗Veru Inc. (VERU) ↗VolitionRx Limited (VNRX) ↗Vor Biopharma Inc. Common Stock (VOR) ↗XBiotech Inc (XBIT) ↗Xilio Therapeutics, Inc. Common Stock (XLO) ↗
Dates and coverage
Report dates range from 2025-07-28 to 2025-12-31. Market observations range from 2026-10-08 to 2026-10-09. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 82 companies without a report, 0 with invalid latest rating metadata, 1 with older reports, 2 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.